Clever Leaves Holdings Inc. is a global pharmaceutical company specializing in the cultivation, extraction, and distribution of cannabinoid-based products. With operations anchored in Colombia, the company produces EU Good Manufacturing Practice (GMP) certified cannabinoid active pharmaceutical ingredients (APIs) and finished products in both flower and extract forms. Clever Leaves serves a diverse business-to-business client base, supplying pharmaceutical-grade cannabis products to partners in over 15 countries. Its portfolio spans cannabis flowers, CBD isolates, full-spectrum and standardized extracts, and a variety of nutraceutical and wellness products. The company is recognized for its large-scale, environmentally sustainable cultivation practices, leveraging natural resources to minimize environmental impact while maintaining stringent pharmaceutical quality standards. Clever Leaves plays a significant role in shaping global cannabis supply chains by enabling efficient, compliant, and cost-effective access to cannabinoid therapeutics and wellness products for pharmaceutical companies, retailers, and pharmacies worldwide.